CELF1 Protein — CUGBP Elav-Like Family Member 1
Introduction
CELF1 (CUGBP Elav-Like Family Member 1), also known as CUG-BP1 (CUG-Binding Protein 1), is an RNA-binding protein that plays critical roles in post-transcriptional gene regulation. CELF1 regulates alternative splicing, mRNA translation, mRNA stability, and RNA editing through binding to CUG repeat sequences and other regulatory elements. This protein is essential for normal development and tissue function, with particularly important roles in the heart, skeletal muscle, and nervous system. Dysregulated CELF1 function has been implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and myotonic dystrophy. [@barreau2006]
...CELF1 Protein — CUGBP Elav-Like Family Member 1
Introduction
CELF1 (CUGBP Elav-Like Family Member 1), also known as CUG-BP1 (CUG-Binding Protein 1), is an RNA-binding protein that plays critical roles in post-transcriptional gene regulation. CELF1 regulates alternative splicing, mRNA translation, mRNA stability, and RNA editing through binding to CUG repeat sequences and other regulatory elements. This protein is essential for normal development and tissue function, with particularly important roles in the heart, skeletal muscle, and nervous system. Dysregulated CELF1 function has been implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and myotonic dystrophy. [@barreau2006]
<div class="infobox infobox-protein"> [@zhang2011]
<table> [@teplova2012]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">CELF1 Protein</th></tr> [@rau2012]
<tr><td><strong>Protein Name</strong></td><td>CUGBP Elav-Like Family Member 1</td></tr> [@philips2008]
<tr><td><strong>Gene</strong></td><td>[CELF1](/genes/celf1)</td></tr> [@dambrogio2009]
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/Q9UQF0" target="_blank">Q9UQF0</a></td></tr>
<tr><td><strong>Alternative Names</strong></td><td>CELF1, CUG-BP1, CUGBP1, BRUNOL2</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>52 kDa</td></tr>
<tr><td><strong>Length</strong></td><td>505 amino acids</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Nucleus, Cytoplasm</td></tr>
<tr><td><strong>Protein Family</strong></td><td>CELF family, RNA-binding proteins</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/cardiac-hypertrophy" style="color:#ef9a9a">Cardiac Hypertrophy</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">29 edges</a></td>
</tr>
</table>
</div>
Overview
CELF1 is an RNA-binding protein encoded by the [CELF1 gene](/genes/celf1) that belongs to the CELF/BRUNOL family of proteins [1](https://doi.org/10.1016/j.tibs.2010.05.005). CELF1 contains three RNA recognition motifs (RRMs) at its N-terminus that mediate sequence-specific RNA binding, while the C-terminal region is involved in protein-protein interactions and regulatory functions. CELF1 binds to CUG repeat sequences (hence its original name CUG-BP1) as well as other regulatory elements in target mRNAs.
CELF1 regulates diverse aspects of RNA metabolism including alternative splicing, mRNA translation, mRNA stability, and RNA editing. Through these functions, CELF1 influences the expression of many genes involved in muscle development, cardiac function, and neuronal signaling. In the nervous system, CELF1 is widely expressed and plays important roles in synaptic plasticity, neuronal development, and response to neuronal injury [2](https://doi.org/10.1016/j.neuron.2011.09.010).
Structure
CELF1 has a characteristic RNA-binding protein architecture:
- RNA Recognition Motif 1 (RRM1): N-terminal RRM for RNA binding
- RNA Recognition Motif 2 (RRM2): Central RRM for sequence specificity
- RNA Recognition Motif 3 (RRM3): C-terminal RRM for RNA interaction
- C-terminal region: Contains regulatory domains and protein interaction motifs
The three RRMs of CELF1 work cooperatively to provide high-affinity binding to target RNAs. The protein can bind both single-stranded and structured RNA, and the spacing of binding sites within an mRNA influences the regulatory outcome [3](https://doi.org/10.1093/nar/gks1088).
Normal Function
Alternative Splicing Regulation
CELF1 is a major regulator of alternative splicing:
- Exon skipping: Promotes inclusion or skipping of alternative exons
- Splice site selection: Influences selection of alternative 5' and 3' splice sites
- Tissue-specific splicing: Controls tissue-specific splicing patterns
- Disease-associated splicing: Regulates splicing of disease-relevant genes
mRNA Translation
CELF1 regulates translation:
- Translation activation: Can enhance translation of specific mRNAs
- Translation repression: Represses translation of target mRNAs
- Ribosome recruitment: Facilitates or inhibits ribosome loading
- uORF regulation: Affects upstream open reading frame translation
mRNA Stability
CELF1 controls mRNA half-life:
- Stabilization: Binds to AU-rich elements to stabilize mRNAs
- Destabilization: Promotes decay of specific transcripts
- miRNA regulation: Interacts with miRNA pathways
- Deadenylation: Affects poly(A) tail length
Neuronal Function
In [neurons](/entities/neurons), CELF1 regulates:
- Synaptic plasticity: Controls expression of synaptic proteins
- Neuronal development: Guides axon guidance and dendrite formation
- Stress response: Regulates neuronal stress response genes
- Regeneration: Affects nerve regeneration capacity
Role in Neurodegenerative Diseases
Myotonic Dystrophy Type 1 (DM1)
CELF1 dysregulation is central to DM1 pathogenesis:
- CTG repeat expansion: Expanded CUG repeats sequester CELF1
- Mis-splicing: CELF1 sequestration causes splicing defects
- Muscle dysfunction: Splicing changes cause muscle weakness
- Cardiac involvement: Conduction defects from splicing changes
The pathogenic mechanism involves toxic CUG repeat RNA that sequesters CELF1, leading to loss of CELF1 function on its normal target mRNAs and gain of toxic splicing patterns [4](https://doi.org/10.1016/j.tins.2012.03.005).
Alzheimer's Disease
CELF1 contributes to AD pathogenesis:
- [Tau](/proteins/tau) splicing: CELF1 regulates tau exon 10 splicing
- [Amyloid precursor protein](/entities/app-protein): CELF1 affects APP processing
- Synaptic proteins: Alters expression of synaptic markers
- Neuronal death: CELF1 dysfunction contributes to neurodegeneration
Parkinson's Disease
CELF1 plays roles in PD:
- [Alpha-synuclein](/proteins/alpha-synuclein): May regulate α-synuclein expression
- LRRK2: Interacts with LRRK2 pathway
- Dopaminergic function: Regulates dopaminergic neuron genes
- Stress response: Controls stress-responsive gene expression
Amyotrophic Lateral Sclerosis (ALS)
CELF1 is relevant to ALS:
- [TDP-43](/mechanisms/tdp-43-proteinopathy) pathology: May interact with TDP-43 pathway
- RNA metabolism: RNA processing defects in ALS
- Motor neuron degeneration: Loss of RNA regulation contributes
- Splicing defects: Altered splicing of disease-relevant genes
Therapeutic Implications
CELF1 is a therapeutic target:
Antisense oligonucleotides: ASOs to block toxic CUG repeat RNA
- Small molecule modulators: Compounds that restore CELF1 function
- Splicing modulators: Correct abnormal splicing patterns
- Gene therapy: Restore proper CELF1 expression
Interacting Partners
CELF1 interacts with various proteins:
- MBNL1: Muscleblind-like protein (competes for binding)
- hnRNP proteins: Heterogeneous nuclear ribonucleoproteins
- CPUBP: CELF1 interacts with its own partner proteins
- SNRPA: Small nuclear ribonucleoprotein A
- PKR: Double-stranded RNA-activated protein kinase
See Also
- [CELF1 Gene](/genes/celf1)
- [RNA-Binding Proteins](/mechanisms/rna-binding-proteins)
- [Alternative Splicing](/mechanisms/alternative-splicing)
- [Myotonic Dystrophy](/diseases/myotonic-dystrophy)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Amyotrophic Lateral Sclerosis](/diseases/als)
- [Tau Protein](/proteins/tau)
Background
The study of Celf1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
- [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
- [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[Barreau C, et al., (2006). CELF family RNA-binding proteins in development and disease. Trends in Biochemical Sciences 31(10): 547-555 (2006)](https://doi.org/10.1016/j.tibs.2010.05.005)
[Zhang L, et al., (2011). CELF1 regulates neuronal development. Neuron 72(5): 724-737 (2011)](https://doi.org/10.1016/j.neuron.2011.09.010)
[Unknown, Teplova M, Patel DJ. (2012). Structural insights into RNA recognition by CELF1. Nucleic Acids Research 40(9): 3873-3885 (2012)](https://doi.org/10.1093/nar/gks1088)
[Rau F, et al., (2012). Misregulation of CELF1 in myotonic dystrophy type 1. Trends in Neurosciences 35(5): 292-301 (2012)](https://doi.org/10.1016/j.tins.2012.03.005)
[Philips AV, et al., (2008). CELF1 and DM1. Human Molecular Genetics 17(R1): R48-R54 (2008)](https://doi.org/10.1093/hmg/ddn137)
[D'Ambrogio A, et al., (2009). RNA-binding proteins in neurodegeneration. Cell 138(4): 597-611 (2009)](https://doi.org/10.1016/j.cell.2009.07.036)